Results 191 to 200 of about 337,480 (272)
High‐risk cardiac patients may benefit from timely temporary mechanical circulatory support (tMCS) implantation to provide perioperative hemodynamic stabilization and circulatory support, thus enabling them to undergo life‐saving thoracic surgery. CPB: cardiopulmonary bypass; IABP: intra‐aortic balloon pump; tMCS: temporary mechanical circulatory ...
Viviana Teresa Agosta+4 more
wiley +1 more source
Frailty significantly impacts clinical outcomes in LVAD recipients. This systematic review and meta‐analysis reveal that frail patients experience higher long‐term mortality but comparable short‐term mortality, hospital stay, and complication rates to non‐frail patients.
Christos Costa+15 more
wiley +1 more source
Slow Codes are symptomatic of ethically and legally inappropriate CPR policies
Abstract Although cardiopulmonary resuscitation (CPR) was initially used very selectively at the discretion of clinicians, the use of CPR rapidly expanded to the point that it was required to be performed on all patients having in‐hospital cardiac arrests, regardless of the underlying condition.
Stuart McLennan+2 more
wiley +1 more source
Schematic representation of the effects of rmMFG‐E8 on post‐CA/CPR brain injury. Ischemic/reperfusion injury caused by CA/RCA results in elevated apoptotic cell death in various cells and decreased apoptotic cell clearance by phagocytes, such as microglia.
Kunxue Zhang+9 more
wiley +1 more source
A Talk with ChatGPT: The Role of Artificial Intelligence in Shaping the Future of Cardiology and Electrophysiology. [PDF]
Cersosimo A+4 more
europepmc +1 more source
Late‐onset multiple system atrophy (LO‐MSA; onset ≥75 years) shows milder degeneration of the striatonigral and olivopontocerebellar systems and serotonergic neurons in the ventrolateral medulla than usual‐age‐onset MSA with a similar disease duration. LO‐MSA may therefore exhibit slower pathological progression.
Misato Ozawa+13 more
wiley +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen+3 more
wiley +1 more source
Acquired Genotype-Positive Long QT Syndrome After Pediatric Heart Transplantation. [PDF]
Barresi NV+3 more
europepmc +1 more source
Abstract Background and Purpose Congenital long QT syndrome (LQTS) involves genetic mutations affecting ion channels, leading to a prolonged QT interval and increased risk of potentially lethal ventricular arrhythmias. Mutations in the genes encoding KV7.1/KCNE1 are the most frequent, with channel loss‐of‐function contributing to LQTS.
Irene Hiniesto‐Iñigo+11 more
wiley +1 more source